ChromaDex Closes Reverse Merger

IRVINE, Calilf.—ChromaDex Inc. completed its reverse merger with CDI Acquisition Inc., a wholly owned subsidiary of Cody Resources Inc. (OTCBB: CDYE). Under terms of the merger, ChromaDex becomes a wholly owned subsidiary of Cody, and each outstanding share of ChromaDex common stock automatically converts into the right to receive one share of common stock of Cody. In the end, ChromaDex shareholders own or have the right to own, in the aggregate, approximately 23.5 million shares, or 84 percent, of the outstanding CDYE common stock. The business and operations of ChromaDex will remain unchanged, although its incorporation from Nevada to Delaware, and it name changes to ChromaDex Corp.

ChromaDex said the transaction enables it to be wholly owned by a company with publicly traded shares, which will help it be better positioned to meet the ongoing needs of a rapidly growing marketplace. ChromaDex further said it should continue to meet demand for analytical tools, products and services that promote compliance with regulatory, quality, efficacy and safety standards for their products.

"We are pleased to have completed this reverse merger as a means of achieving public ownership for ChromaDex," said Frank Jaksch, CEO and co-founder of ChromaDex. "This merger into the public arena affords ChromaDex benefits of public ownership, including the ability to enhance our visibility with customers and prospective customers, additional liquidity for existing and future equity investors, and access to potential additional avenues for capital formation to help us grow and expand to meet the needs of the sizable natural product chemistry, dietary supplement, functional food, cosmetic and pharmaceutical marketplaces with our unique skill set and value proposition." He added merger provides ChromaDex with a foundation for new opportunities to better meet the needs of the customer as well as the benefits of an ongoing public market valuation.